APA

Pandey S. K., Wheeler T. M., Justice S. L., Kim A., Younis H. S., Gattis D., Jauvin D., Puymirat J., Swayze E. E., Freier S. M., Bennett C. F., Thornton C. A. & MacLeod A. R. (20160104). Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. : The Journal of pharmacology and experimental therapeutics.

Chicago

Pandey Sanjay K, Wheeler Thurman M, Justice Samantha L, Kim Aneeza, Younis Husam S, Gattis Danielle, Jauvin Dominic, Puymirat Jack, Swayze Eric E, Freier Susan M, Bennett C Frank, Thornton Charles A and MacLeod A Robert. 20160104. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. : The Journal of pharmacology and experimental therapeutics.

Harvard

Pandey S. K., Wheeler T. M., Justice S. L., Kim A., Younis H. S., Gattis D., Jauvin D., Puymirat J., Swayze E. E., Freier S. M., Bennett C. F., Thornton C. A. and MacLeod A. R. (20160104). Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. : The Journal of pharmacology and experimental therapeutics.

MLA

Pandey Sanjay K, Wheeler Thurman M, Justice Samantha L, Kim Aneeza, Younis Husam S, Gattis Danielle, Jauvin Dominic, Puymirat Jack, Swayze Eric E, Freier Susan M, Bennett C Frank, Thornton Charles A and MacLeod A Robert. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. : The Journal of pharmacology and experimental therapeutics. 20160104.